Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 22, 2020 | PDC*line Pharma | $15.4M Series B | — | Sangwoo Lee, Noshaq, Sambrinvest, SFPI-FPIM, Shinhan-Cognitive Start-up Fund, UTC 2019 BIOVENTUREFUND |
| Feb 19, 2018 | Synergia Medical | $10.1M Series A | Alain Parthoens | Pierre Detrixhe, SFPI-FPIM, SRIW |
| Dec 6, 2016 | PDC*line Pharma | $4.3M Debt / Other Equity | — | Baudouin Jolly, Jean-Paul Prieels, Riccardo Cortese, SERGE GOBLET, Auvergne-Rhône-Alpes Initiative, Noshaq, Parness, Spinventure, Wallonia Biotech Coaching incubator |
| Nov 21, 2013 | iSTAR Medical | $5.4M Series A | Ekaterina Smirnyagina, Philippe Degive | Namur Invest |
| Mar 28, 2012 | Promethera Biosciences | $31.4M Debt / Series B | — | ATMI, Boehringer Ingelheim, Life Sciences Research Partners, Mitsui & Co. Global Investment, Nivelinvest, Sambrinvest, Shire, Sopartec, SRIW, Vesalius Biocapital, VIVES Louvain Technology Fund, Walloon Region |